Literature DB >> 26682336

Additional thoughts on the new treatment Kybella.

Joel L Cohen, David L K Chen, Jeremy B Green, John H Joseph.   

Abstract

With the recent approval of Kythera Biopharmaceuticals (Westlake Village, California) submental fat injectable treatment Kybella, there comes a lot of excitement-but, also a bit of concern. The idea of having a nonsurgical, nonliposuction treatment for people who have a double chin is certainly exciting. The hope has been that this new treatment will provide opportunities for the many people out there who are focused on the appearance of their submental fullness to have access to a safe. affordable, and reliable treatment.With the approval of this product. there are several misconceptions that the authors herein discuss.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26682336     DOI: 10.12788/j.sder.2015.0175

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

1.  Current Trends in Management of Submental Liposis: A Pooled Analysis and Survey.

Authors:  Sagar Patel; Russell Kridel
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

2.  Alopecia after injection of ATX-101 for reduction of submental fat.

Authors:  Skylar Souyoul; Olivia Gioe; Ashley Emerson; Deirdre O'Boyle Hooper
Journal:  JAAD Case Rep       Date:  2017-05-23

3.  Biodegradable, bile salt microparticles for localized fat dissolution.

Authors:  Hanieh Safari; Nicholas Kaczorowski; Michael L Felder; Emma R Brannon; Mita Varghese; Kanakadurga Singer; Omolola Eniola-Adefeso
Journal:  Sci Adv       Date:  2020-12-04       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.